Cargando…
The incidence, risk factors, and survival of acute myeloid leukemia secondary to myelodysplastic syndrome: A population‐based study
To determine the incidence, risk factors, and relative survival of acute myeloid leukemia (AML) secondary to myelodysplastic syndrome (MDS) in the Surveillance, Epidemiology, and End Results (SEER) database. Retrospective analysis of all patients with new MDS onset in the SEER‐18 database from 2001...
Autores principales: | Ye, Xingnong, Chen, Dan, Zheng, Yan, Wu, Cai, Zhu, Xiaoqiong, Huang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900108/ https://www.ncbi.nlm.nih.gov/pubmed/31378958 http://dx.doi.org/10.1002/hon.2660 |
Ejemplares similares
-
Effective treatment of low-dose decitabine in myelodysplastic syndrome/myeloproliferative neoplasms
por: Ye, Xingnong, et al.
Publicado: (2017) -
Ruxolitinib Plus Decitabine Effectively Treats Myelodysplastic Syndrome/Myeloproliferative Neoplasm, Unclassifiable, by Decreasing the Variant Allele Frequency of KRAS
por: Luo, Shuna, et al.
Publicado: (2020) -
310 Mechanisms of progression of myelodysplastic syndrome to fatal secondary acute myeloid leukemia
por: Chang, Daniel, et al.
Publicado: (2023) -
Secondary Acute Myeloid Leukemia in Myelodysplastic Syndrome Patients Aged Over 60 Years
por: Chaudhuri, Dipabali, et al.
Publicado: (2023) -
Epigenetic Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemias
por: Leone, Giuseppe, et al.
Publicado: (2008)